ID 63 - Kwas pantotenowy

PL: Kwas pantotenowy
EN: Panthothenic acid
Pdf: pantothenic acid

Oświadczenie (4)

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent that is the subject of the health claims is pantothenic acid which is a well recognised nutrient and is measurable in foods by established methods.
Pantothenic acid occurs naturally in foods and is authorised for addition to foods (Annex I of Regulation (EC) No 1925/20066 and Annex I of Directive 2002/46/EC7). This evaluation applies to pantothenic acid naturally present in foods and to those forms authorised for addition to foods (Annex II of Regulation (EC) No 1925/2006 and Annex II of Directive 2002/46/EC).
The Panel considers that the food constituent, pantothenic acid, which is the subject of the health claims is sufficiently characterised.

2.2. Zmniejszenie zmęczenia (ID 63)

The claimed effect is “vitamin/mineral supplementation to reduce fatigue and tiredness in situations of inadequate micronutrient status”. The Panel assumes that the target population is the general population.
The Panel considers that reduction of tiredness and fatigue is a beneficial physiological effect.

3. Naukowe uzasadnienia wpływu na zdrowie człowieka - 

Pantothenic acid is required for the synthesis of coenzyme A (CoA), a cofactor and acyl group carrier for many enzymatic processes and for the synthesis of the prosthetic group of the acyl carrier protein (ACP), a component of the fatty acid synthesis complex. Most tissues transport pantothenic acid into cells for the synthesis of CoA (IoM, 1998). The evidence for the essentiality of pantothenic acid consists of its well known role in cellular biochemistry.
Deficiency symptoms have only been observed in experimental settings such as giving a pantothenic acid metabolic antagonist and not in dietary studies. Deficiency symptoms included irritability, restlessness, fatigue, apathy, malaise, sleep disturbances, numbness and muscle cramps (IoM, 1998).

3.1. Zmniejszenie zmęczenia (ID 63)

Deficiency symptoms of pantothenic acid in experimental settings include fatigue (IoM, 1998).
The Panel concludes that a cause and effect relationship has been established between the dietary intake of pantothenic acid and reduction of tiredness and fatigue. However, the evidence provided does not establish that inadequate intake of pantothenic acid leading to tiredness and fatigue occurs in the general EU population.

4.1. Zmniejszenie zmęczenia (ID 63)

The Panel considers that the following wording reflects the scientific evidence: “Pantothenic acid can contribute to the reduction of tiredness and fatigue”.

Warunki i możliwe ograniczenia stosowania oświadczenia

Must meet minimum requirements for use of the claim "source of [name of vitamin/s] and/or [name of mineral/s]," as per Annex to Regulation 1924/2006.